
Pharmaceuticals
What This Page Covers
This page collects the 143 public records POLISCOPE has tagged with “Pharmaceuticals”. Coverage spans bills and news coverage - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Health, and Fda.
Active Bills
Recent Activity
- Mon, Nov 23 items
- FDA approves generic HIV-prevention shot lenacapavir for 120 low- and middle-income countries at $40 a yearThe U.S. Food and Drug Administration granted tentative approval to a generic version of the twice-a-year HIV-prevention shot lenacapavir, paving the way for distribution in 120 low- and middle-income
- FDA approves generic lenacapavir HIV-prevention shot for low-income countries at $40 a year
- FDA approves generic version of biannual HIV-prevention shot lenacapavir for 120 low- and middle-income countries
- Thu, Oct 292 items
- Researchers study cancer drug trastuzumab rezetecan for advanced breast cancerA clinical trial found that the cancer-killing drug trastuzumab rezetecan delayed cancer progression and shrank tumors in three out of four patients with ERBB2-low advanced breast cancer compared to s
- Eli Lilly reports clinical trial results for weight loss drug retatrutide
- Tue, Oct 271 item
- Fri, Oct 231 item
- Mon, Sep 141 item
Finance Signals
No finance signals found for this topic in the available records yet.
Open the Money page to search by entity, donor, or PAC.
Reported financial relationships and timing signals. This does not prove motive or influence.
Key Actors
- 01Food and Drug Administrationorganization5 mentions
- 02Unitaidorganization3 mentions
- 03504950other3 mentions
- 04U.S. Food and Drug Administrationorganization3 mentions
- 05Wits RHIorganization3 mentions
- 06Dr. Reddy’s Laboratoriesorganization3 mentions
- 07Clinton Health Access Initiativeorganization3 mentions
- 08Vitruvias Therapeutics, Inc.organization3 mentions
- 09Gilead Sciencesorganization3 mentions
- 10Merckorganization3 mentions
Connections Preview
Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.
- Topic to billsProposed Changes to Biosimilar Drug Review Process
- Topic to orgsFood and Drug Administration, Unitaid, U.S. Food and Drug Administration (+6 more)
Source Trail
Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.
- Nov 2, 2026NewsFDA approves generic HIV-prevention shot lenacapavir for 120 low- and middle-income countries at $40 a year
- Nov 2, 2026NewsFDA approves generic lenacapavir HIV-prevention shot for low-income countries at $40 a year
- Nov 2, 2026NewsFDA approves generic version of biannual HIV-prevention shot lenacapavir for 120 low- and middle-income countries
- Oct 29, 2026NewsResearchers study cancer drug trastuzumab rezetecan for advanced breast cancer
- Oct 29, 2026NewsEli Lilly reports clinical trial results for weight loss drug retatrutide
- Oct 27, 2026NewsAnalysis links SGLT2 inhibitor diabetes and kidney drugs to longer survival in adults over 80
- Oct 23, 2026NewsExperimental mRNA Vaccine Combined with Keytruda Reduces Melanoma Relapse Risk
- Sep 14, 2026NewsNavigator Research Poll Identifies Prescription Drug Companies and Health Insurers Among Most Corrupt Industries
- Sep 9, 2026NewsNew study links semaglutide to reduced asthma attacks and COPD flare-ups
- Aug 31, 2026NewsFlorida Attorney General investigates Pharmacy Benefit Managers for alleged monopolistic practices
Showing 10 of 143 source records.
